US Panel: AstraZeneca Heart Drug OK with Others (Reuters)
Reuters - AstraZeneca Plc should be
allowed to market its hypertension drug Atacand to heart
failure patients taking other heart medicines called ACE
inhibitors, U.S. experts recommended on Thursday, despite
finding problems with a trial of the medicine.
Read more...
Stumble It!
Tweet This
Bookmark on Delicious
Share on Facebook
Share on MySpace